Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Transplantation Of Cultured Cells

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 2 (1)
Phase 2/3 (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT01619189Phase 2CompletedPrimary

Cell Therapy in Failure Syndromes in Limbal Stem Cells

NCT01237600Phase 2/3Completed

Efficacy of Cultivated Corneal Epithelial Stem Cell for Ocular Surface Reconstruction

Showing all 2 trials

Research Network

Common Treatments

  • Transplantation Of Cultured Cells1
  • Cultivated Limbal Transplantation1
  • Epithelial Stem Cells Cultured1

Active Sponsors

  • Etablissement Français du Sang1
  • Mahidol University1
  • Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts1

Top Investigators

Related Conditions

  • Severe Ocular Surface Damage1

Activity Timeline